Current price is more than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Based on the open interest future percentage, a short-covering was seen in 109 stocks including Bank Nifty, Coforge, GNFC, Bandhan Bank, and Alembic Pharmaceuticals

Trade setup for today: Top 15 things to know before the opening bell

Alembic Pharmaceuticals on Friday said it has received approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancers, in the American market

Alembic Pharma gets USFDA nod for cancer treatment drug in US market

Dasatinib tablets are used for the treatment of adult patients with leukaemia-related ailments.

Alembic Pharma gets tentative USFDA approval for its Dasatinib tablets

The pharmaceutical company on Friday announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Dasatinib tablets.

Alembic Pharma gets USFDA nod for leukemia drug

Alembic Pharmaceuticals gets USFDA approval

Alembic Pharmaceuticals said it has received approval from the US health regulator to market Pirfenidone tablets used to treat lung disease in the American market.

Alembic Pharma gets USFDA approval to market Pirfenidone tablets

Alembic Pharma has received USFDA approval to market Pirfenidone tablets, used to treat a lung disease, in the American market.

Alembic Pharma Gets USFDA Approval To Market Pirfenidone Tablets In U.S.

The inhalation solution is for long-term treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease.

Alembic Pharma Gets Final U.S. FDA Nod For Generic Version Of Arformoterol Tartrate Inhalation Solution

The approval by the US Food & Drug Administration (USFDA) for the abbreviated new drug application (ANDA) for Arformoterol Tartrate inhalation solution is for strength of 15 mcg (base)/2 mL unit-dose vial, the company said in a statement.

Alembic Pharma gets final USFDA nod for generic version of Arformoterol Tartrate inhalation solution

This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies Private Limited.

Alembic Pharma gets USFDA final nod for Arformoterol Tartrate inhalation solution

KR Choksey recommended hold rating on Alembic Pharmaceuticals with a target price of Rs 758 in its research report date May 05, 2022.

Hold Alembic Pharmaceuticals; target of Rs 758: KR Choksey

Alembic Pharmaceuticals Limited is a pharmaceutical company engaged in developing formulations and active pharmaceutical ingredients (API).

Alembic Pharmaceuticals Ltd

Alembic Pharmaceuticals Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Trade setup for today: Top 15 things to know before the opening bell

Alembic Pharma gets USFDA nod for cancer treatment drug in US market

Alembic Pharma gets tentative USFDA approval for its Dasatinib tablets

Alembic Pharma gets USFDA nod for leukemia drug

Alembic Pharmaceuticals gets USFDA approval

Alembic Pharma gets USFDA approval to market Pirfenidone tablets

Alembic Pharma Gets USFDA Approval To Market Pirfenidone Tablets In U.S.

Alembic Pharma Gets Final U.S. FDA Nod For Generic Version Of Arformoterol Tartrate Inhalation Solution

Alembic Pharmaceuticals Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Trade setup for today: Top 15 things to know before the opening bell

Alembic Pharma gets USFDA nod for cancer treatment drug in US market

Alembic Pharma gets tentative USFDA approval for its Dasatinib tablets

Alembic Pharma gets USFDA nod for leukemia drug

Alembic Pharmaceuticals gets USFDA approval

Alembic Pharma gets USFDA approval to market Pirfenidone tablets

Alembic Pharma Gets USFDA Approval To Market Pirfenidone Tablets In U.S.

Alembic Pharma Gets Final U.S. FDA Nod For Generic Version Of Arformoterol Tartrate Inhalation Solution

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock